Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 84 (5), 517-522
- https://doi.org/10.1016/s1081-1206(10)62515-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effectiveness and Safety of Fexofenadine, a New Nonsedating H1-Receptor Antagonist, in the Treatment of Fall AllergiesAllergy and Asthma Proceedings, 1998
- ABC of allergies: Allergy and the skin. I---UrticariaBMJ, 1998
- The pathogenesis of chronic idiopathic urticariaArchives of Dermatology, 1997
- The impact of chronic urticaria on the quality of lifeBritish Journal of Dermatology, 1997
- Histamine: The Quintessential MediatorThe Journal of Dermatology, 1996
- Update on Urticaria and Angioedema (Hives)Allergy and Asthma Proceedings, 1995
- Chronic UrticariaNew England Journal of Medicine, 1995
- H1-Receptor AntagonistsDrug Safety, 1994
- Allergic skin disorders and mastocytosisPublished by American Medical Association (AMA) ,1992
- Urticaria: Current therapyJournal of Allergy and Clinical Immunology, 1990